RecruitingPhase 2NCT05798923
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Sponsor: IRulya Therapeutics Inc.
Tucson, AZ · +3 more sites
Hypertension clinical trials in Tucson, AZ
10 recruiting hypertension studies with a site in Tucson, AZ.
RecruitingPhase 3NCT07181109
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Sponsor: Alnylam Pharmaceuticals
Chandler, AZ · Gilbert, AZ · Glendale, AZ · +270 more sites
RecruitingPhase 2NCT07783802
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Sponsor: Eli Lilly and Company
Tucson, AZ · +28 more sites
RecruitingNot applicableNCT07214376
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
Sponsor: Pulnovo Medical, Inc.
Tucson, AZ · +11 more sites
RecruitingPhase 2NCT07142356
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Sponsor: Retension Pharmaceuticals. Inc.
Tucson, AZ · +33 more sites
RecruitingPhase 3NCT06742723
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Sponsor: AstraZeneca
Surprise, AZ · Tucson, AZ · +131 more sites
RecruitingNot applicableNCT07799961
Arizona CEAL: Linking Social Care With Healthcare Systems to Address SDOH
Sponsor: Sairam Parthasarathy
Tucson, AZ
RecruitingEarly Phase 1NCT07687745
Breathing for Two: Inspiratory Muscle Strength Training for Supporting Healthy Blood Pressure in Pregnancy
Sponsor: University of Arizona
Tucson, AZ
Not yet recruitingPhase 2NCT07601295
Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)
Sponsor: Stanford University
Tucson, AZ · +9 more sites
Not yet recruitingPhase not listedNCT07487441
Reverse Remodeling of the Pulmonary Vasculature: a Longitudinal, Investigational Study of the Effects of Sotatercept.
Sponsor: Franz Rischard, DO
Tucson, AZ
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.